Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

NRX Pharmaceuticals (NRXP) Interest & Investment Income (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed Interest & Investment Income for 2 consecutive years, with $4000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income changed 0.0% to $4000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12000.0 through Dec 2025, down 72.73% year-over-year, with the annual reading at $12000.0 for FY2025, 72.73% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $4000.0 at NRX Pharmaceuticals, up from $2000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $27000.0 in Q1 2024, with the low at $2000.0 in Q2 2025.